Status:

Do Not Prescribe (DNP), Red

Decision Date:

October 2019

Comments

RED: NICE TA628: Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer (Decision date - June 2020)

DNP: NICE TA909: Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer. (Decision date - August 2023)

 

NHSE commissioned

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again